联系我们
Isaac Scientific Publishing
Modern Clinical Medicine Research
Prof. SULEYMAN AYDIN,  Firat University, Turkey
Department of Medical Biochemistry (Firat Hormones Research Group),
Medical School, Firat University,23119 Elazig, TURKEY
Selected Publications
A1. INTERNATIONAL ARTICLES AND REVIEWS
DERLEMELER
A1.1. Aydin, S., D.A. Webster, and B.C. Stark, “Nitrite inhibition of Vitreoscilla hemoglobin (VHb) in recombinant E. coli: Direct evidence that VHb enhances recombinant protein production,” Biotech Prog, 16, 917-21 (2000).
A1.2. Sahin, K., M. Onderci, N. Sahin, and S. Aydin, “Effects of dietary chromium picolinate and ascorbic acid supplementation on egg production, egg quality and some serum metabolites of laying hens reared under a low ambient temperature (6 degrees C),” Archives of Animal Nutrition, 56, 41-9 (2002).
A1.3. Sahin, K., M. Onderci, N. Sahin, M.F. Gursu, and S. Aydin, “Cold-induced elevation of homocysteine and lipid peroxidation can be alleviated by dietary folic acid supplementation,” Nutr Res., 23, 357-65 (2003).
A1.4. Kumru, S., S. Aydin, M. Simsek, K. Sahin, M. Yaman, and G. Ay, “Comparison of serum copper, zinc, calcium, and magnesium levels in preeclamptic and healthy pregnant women,” Biol Trace Elem Res, 94, 105-12 (2003).
A1.5. Aydin, S., “Menadione knocks out Vitreoscilla haemoglobin (VHb): the current evidence for the role of VHb in recombinant Escherichia coli,” Biotechnol Appl Biochem, 38, 71-6 (2003).
A1.6. Aydin, S., I. Aral, N. Kilic, I. Bakan, S. Aydin, and F. Erman, “The level of antioxidant enzymes, plasma vitamins C and E in cement plant workers,” Clin Chim Acta, 341, 193-8 (2004).
A1.7. Halifeoglu, I., B. Gur, S. Aydin, and A. Ozturk, “Plasma trace elements, vitamin B12, folate, and homocysteine levels in cirrhotic patients compared to healthy controls,” Biochemistry (Mosc), 69, 693-6 (2004).
A1.8. Kumru, S., S. Aydin, M.F. Gursu, and Z. Ozcan, “Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women,” Eur J Obstet Gynecol Reprod Biol, 114, 177-81 (2004)
A1.9. Aydin, S., “Antioxidant status, alpha-amylase production, growth, and survival of hemoglobin bearing Escherichia coli exposed to hypochlorous acid,” Biochemistry (Mosc), 70, 1369-76 (2005)
A1.10. Kilic, S.S., S. Aydin, N. Kilic, F. Erman, S. Aydin, and I. Celik, “Serum arylesterase and paraoxonase activity in patients with chronic hepatitis,” World J Gastroenterol, 11, 7351-4 (2005).
A1.11. Kumru, S., S. Aydin, A. Aras, M.F. Gursu, and F. Gulcu, “Effects of surgical menopause and estrogen replacement therapy on serum araoxonase activity and plasma malondialdehyde concentration,” Gynecol Obstet Invest, 59, 108-12 (2005).
A1.12. Kumru, S., R. Ozmerdivenli, S. Aydin, A. Yaşar, N. Kilic, C. Parmaksiz, and S. Aydin, “Effects of regular physical exercise on serum leptin and androgen concentrations in young women,” The Journal of Men's Health & Gender, 2, 218-222 (2005).
A1.13. Aydin, S., I. Halifeoglu, I.H. Ozercan, F. Erman, N. Kilic, S. Aydin, N. Ilhan, N. Ilhan, Y. Ozkan, N. Akpolat, L. Sert, and E. Caylak, “A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects,” Peptides, 26, 647-52 (2005).
A1.14. Aydin, S., I.H. Ozercan, F. Dagli, S. Aydin, O. Dogru, S. Celebi, O. Akin, and S.P. Guzel, “Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland,” Biotech Histochem, 80, 163-8 (2005).
A1.15. Onderci, M., N. Sahin, K. Sahin, G. Cikim, A. Aydin, I. Ozercan, and S. Aydin, “Efficacy of supplementation of alpha-amylase-producing bacterial culture on the performance, nutrient use, and gut morphology of broiler chickens fed a corn-based diet,” Poult Sci, 85, 505-10 (2006).
A1.16. Erman, F., S. Aydin, Y. Demir, F. Akcay, and E. Bakan, “Determination of saturated and unsaturated fatty acids amount in leukocyte membranes from subjects fed with solid and fluid oils,” J Biochem Mol Biol, 39, 516-21 (2006).
A1.17. Aydin, S., I.H. Ozercan, S. Aydin, Y. Ozkan, F. Dagli, F. Oguzoncul, and H. Geckil, “Biological rhythm of saliva ghrelin in human,” Biological Rhythm Research, 37, 169-77 (2006).
A1.18. Aydin, S., S. Aydin, Y. Ozkan, and S. Kumru, “Ghrelin is present in human colostrum, transitional and mature milk,” Peptides, 27, 878-82 (2006).
A1.19. Aydin, S., H. Geckil, F. Zengin, H. Ibrahim Ozercan, F. Karatas, S. Aydin, D. Turgut-Balik, Y. Ozkan, F. Dagli, and V. Celik, “Ghrelin in plants: What is the function of an appetite hormone in plants?,” Peptides, 27, 1597-602 (2006).
A1.20. Aydin, S., “A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics,” J Biochem Mol Biol, 40, 29-35 (2007).
A1.21. Aydin, S., I.H. Ozercan, F. Dagli, S. Aydin, S. Kumru, N. Kilic, I. Sahin, and M.R. Ozercan, “Ghrelin is present in teeth,” J Biochem Mol Biol, 40, 368-372 (2007).
A1.22. Aydin, S., H. Geckil, F. Karatas, E. Donder, S. Kumru, E.C. Kavak, R. Colak, Y. Ozkan, and I. Sahin, “Milk and blood ghrelin level in gestational diabetes mellitus,” Nutrition, 23, 807-11 (2007).
A1.23. Aydin, S., “Discovery of ghrelin hormone: research and clinical applications,” Turk J Biochem, 32, 76–89 (2007).
A1.24. Caylak, E., İ. Halifeoglu, S. Aydin, S. Telo, O. Bulmus, and H. Celik, “The effects of sulfur-containing compounds on total antioxidant capacity levels of liver, kidney and brain in lead-exposed rats,” Tur Klin J Med Sci, 27, 823-8 (2007).
A1.25. Ozbay, Y., S. Aydin, A. Ferda Dagli, M. Akbulut, N. Dagli, N. Kilic, A. Rahman, İ. Sahin, V. Polat, H. İbrahim Ozercan, N. Arslan, and D. Sensoy, “Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease,” BMB Reports, 41, 55-61 (2008).
A1.26. Aydin, S., S.P. Guzel, S. Kumru, S. Aydin, O. Akin, E. Kavak, I. Sahin, M. Bozkurt, and I. Halifeoglu, “Serum leptin and ghrelin concentrations of maternal serum, arterial and venous cord blood in healthy pregnant and preeclamptic women,” J Physiol Biochem, 64, 51-60 (2008).
A1.27. Aydin, S., Y. Ozkan, F. Erman, B. Gurates, N. Kilic, R. Colak, T. Gundogan, Z. Catak, M. Bozkurt, O. Akin, Y. Sen and I. Sahn, “Presence of obestatin in breast milk: relationship among obestatin, ghrelin, and leptin in lactating women,” Nutrition, 24, 689-93 (2008).
A1.28. Karatas, F., S. Aydin, E. Kaygusuzoglu, H. Yildiz, F.A. Erulas, and Y. Ozkan, “Ghrelin and orotic acid increased in subclinical mastitis,” Arch Physiol Biochem, 114, 178-82 (2008).
A1.29. Rahman, A., S. Aydin, M.K. Bayar, and İ. Sahin, “Changes of ghrelin and brain natriuretic peptide levels in systemic vascular resistance after cardiopulmonary bypass,” J Physiol Biochem, 64, 221-30 (2008).
A1.30. Koca, S.S., M. Ozgen, S. Aydin, S. Dag, B. Evren, and A. Isik, “Ghrelin and obestatin levels in rheumatoid arthritis,” Inflammation, 31, 329-35 (2008).
A1.31. Aydin, S., F. Karatas, and H. Geckil, “Simultaneous quantification of acylated and desacylated ghrelin in biological fluids,” Biomed Chromatogr, 22, 1354-9 (2008).
A1.32. Cetinkaya, Z., S. Aydin, Y.Z. Cerrahoglu, R. Ayten, F. Erman, and E. Aygen, “Changes in appetite hormone (ghrelin) levels of saliva and serum in acute appendicitis cases before and after operation,” Appetite, 52, 104-7 (2009).
A1.33. Karaoglu, A., S. Aydin, A.F. Dagli, D.E. Cummings, I.H. Ozercan, H. Canatan and Y. Ozkan, “Expression of obestatin and ghrelin in papillary thyroid carcinoma,” Mol Cell Biochem, 323, 113-8 (2009).
A1.34. Akin, O.K., M.A. Serdar, Z. Cizmeci, O. Genc, and S. Aydin, “Comparison of UriSed and IQ200 full-automatic urine sediment analyzer with manual urine analysis,” Biotechnol Appl Biochem, 53: 139-44 (2009).
A1.35. Barim, A.O., S. Aydin, R. Colak, E. Dag, O. Deniz, and I. Sahin, “Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment,” Clin Biochem, 42, 1076-81 (2009).
A1.36. Aydin, S., E. Dag, Y. Ozkan, F. Erman, A.F. Dagli, N. Kilic, I. Sahin, F. Karatas, T. Yoldas, A.O. Barim, and Y. Kendir, “Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure,” Mol Cell Biochem, 328, 49-56 (2009).
A1.37. Dagli, A.F., S. Aydin, A. Karaoglu, N. Akpolat, I.H. Ozercan, and M.R. Ozercan, “Ghrelin expression in normal kidney tissue and renal carcinomas,” Pathol Res Pract, 205, 165-73 (2009).
A1.38. Aygen, B., A. Dogukan, F.E. Dursun, S. Aydin, N. Kilic, F. Sahpaz, and H. Celiker, “Ghrelin and obestatin levels in end-stage renal disease,” J Int Med Res, 37, 757-65 (2009).
A1.39. Ozkan, Y., S. Aydin, E. Donder, S.S. Koca, S. Aydin, B. Ozkan, and I. Sahin, “Effect of orlistat on the total ghrelin and leptin levels in obese patients,” J Physiol Biochem, 65, 215-23 (2009).
A1.40. Karatas, F., E. Coteli, S. Aydin, S. Servi, and H. Kara, “Effect of 3-(1H-Pyrrol-2-yl)-1H-Indazole on the antioxidant status of rats,” Biol Trace Elem Res, 136, 79-86 (2010).
A1.41. Alnema, M.M., S. Aydin, Y. Ozkan, A.F. Dagli, H.I. Ozercan, N. Yildirim, I. Sahin, A. Karaoglu, N. Kilic, M. Yilmaz, M.R. Ozercan, and E. Donder, “Ghrelin and obestatin expression in oral squamous cell carcinoma: an immunohistochemical and biochemical study,” Mol Cell Biochem, 339, 173-9 (2010).
A1.42. Erensoy, A., S. Aydin, N. Kelestimur, S. Kirbag, and S. Kuk, “The change of ghrelin levels in intestinal parasitic infections,” J Med Biochem, 29: 34-8 (2010).
A1.43. Aydin, S., S. Aydin, G.A. Croteau, İ. Sahin, and C. Citil, “Ghrelin, nitrite and paraoxonase/arylesterase concentrations in cement plant workers,” J Med Biochem, 29: 78-83 (2010).
A1.44. Dag, E., S. Aydin, Y. Ozkan, F. Erman, A.F. Dagli, and M. Gurger, “Alteration in chromogranin A, obestatin and total ghrelin levels of saliva and serum in epilepsy cases,” Peptides, 31, 932-7 (2010).
A1.45. Temel, İ., O. Celik, S. Hascalik, N. Celik, İ. Sahin, and S. Aydin “Serum nonesterified fatty acids, ghrelin, and homocysteine levels in women with polycystic ovary syndrome,” Turk J Med Sci, 40: 221-8 (2010).
A1.46. Aydin, S., E. Donder, O.K. Akin, F. Sahpaz, Y. Kendir, and M.M. Alnema, “Fat-free milk as a therapeutic approach for constipation and its effect on serum motilin and ghrelin levels,” Nutrition, 26: 981-5 (2010).
A1.47. Aydin, S., “The presence of the peptides apelin, ghrelin and nesfatin-1 in the human breast milk, and the lowering of their levels in patients with gestational diabetes mellitus,” Peptides, 31: 2236-40 (2010).
A1.48. Dagli, A.F., S. Aydin, H. Kocdor, B. Gurates, İ. Sahin, Z. Catak, M.R. Ozercan, and İ.H. Ozercan, “Ghrelin expression of endometrium hyperplasia and endometrioid carcinoma,” Gynecol Endocrinol, 27: 199-204 (2011).
A1.49. Celik, O., N. Celik, S. Hascalik, İ. Sahin, S. Aydin, and E. Ozerol, “An appraisal of serum preptin levels in PCOS” Fertil Steril., 95: 314-6 (2011).
A1.50. Aydin, S., A.F. Dagli, Y. Ozkan, Y. Kendir, İ. Sahin, A. Aksoy, and İ.H. Ozercan, “Immunohistochemical and quantitative analysis of ghrelin in Syzygium aromaticum,” Cell Biology International, 35: 437-41 (2011).
A1.51. Sahin, İ., S. Aydin, Y. Ozkan, A.F. Dagli, K.O. Akin, S.P. Guzel, Z. Catak, and M.R. Ozercan, “Diet-induced obesity suppresses ghrelin in rat gastrointestinal tract and serum,” Mol Cell Biochem, 355: 299-308 (2011).
A1.52. Ozgen, M., S.S. Koca, E.O. Etem, H. Yuce, S. Aydin, and A. Isik. “Ghrelin gene polymorphisms in rheumatoid arthritis,” Joint Bone Spine, 78: 368-73 (2011).
A1.53. Aydin, S., E. Dag, Y. Ozkan, O. Arslan, G. Koc, S. Bek, S. Kirbas, T. Kasikci, D. Abasli, Z. Gokcil, Z. Odabasi, and Z. Catak, “Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients,” Peptides, 32: 1276-80 (2011).
A1.54. Aydin, S., S. Erenler, and Y. Kendir, “Effects of sodium Octanoate, acylated ghrelin, and desacylated ghrelin on the growth of genetically engineered Escherichia coli,” J Med Biochem, 30: 328-333 (2011).
A1.55. Baykus, Y., B. Gurates, S. Aydin, H. Celik, B. Kavak, A. Aksoy, I. Sahin, R. Deniz, S. Gungor, S.P. Guzel, and Y. Minareci, “Changes in serum obestatin, preptin and ghrelins in patients with gestational diabetes mellitus,” Clin Biochem, 45: 198-202 (2012).
A1.56. Simsek, Y., O. Celik, E. Yilmaz, A. Karaer, C. Dogan, S. Aydin, and A. Ozer, “Serum levels of apelin, salusin-alpha, and salusin beta in normal pregnancy and preeclampsia,” J Matern Fetal Neonatal Med, 25: 1705-8 (2012).
A1.57. Aslan, M., O. Celik, N. Celik, I. Turkcuoglu, E. Yilmaz, A. Karaer, Y. Simsek, E. Celik, and S. Aydin, “Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus,” Endocrine, 41: 424-9 (2012).
A1.58. Aydin, S., I. Sahin, Y. Ozkan, E. Dag, A. Gunay, S.P. Guzel, Z. Catak, and M.R. Ozercan, “Examination of the tissue ghrelin expression of rats with diet-induced obesity using radioimmunoassay and immunohistochemical methods,” Mol. Cell Biochem, 365: 165-73 (2012).
A1.59. Deniz, R., B. Gurates, S. Aydin, H. Celik, İ. Sahin, Y. Baykus, Z. Catak, A. Aksoy, C. Citil, and S. Gungor, “Nesfatin-1 and other hormone alterations in polycystic ovary syndrome,” Endocrine, 42: 694-9 (2012).
A1.60. Aydin, S., İ. Sahin, S. Aydin, A. Aksoy, and C. Citil, “The past and present of paraoxonase enzyme: its role in the cardiovascular system and other diseases,” J Med. Biochem, 31: 1-13 (2012).
A1.61. Aydin, S., T. Guven, İ. Sahin, A. Aksoy, Y. Kendir, M.N. İlhan, C. Citil, Z. Catak, and C. Ustun, “The effects of fever on hormone ghrelins, immunoglobulins and heat shock protein 70 expression after swine flu vaccinations,” Endocrine, 42: 352-8 (2012).
A1.62. Kobat, M.A., A. Celik, M. Balin, Y. Altas, A. Baydas, M. Bulut, S. Aydin, N. Dagli, M.F. Yavuzkir, and S. Ilhan, “The investigation of serum vaspin level in atherosclerotic coronary artery disease,” J Clin Med Res, 4: 110-3 (2012).
A1.63. Gunay, H., R. Tutuncu, S. Aydin, E. Dag, and D. Abasli, “Decreased plasma nesfatin–1 levels in patients with generalized anxiety disorder,” Psychoneuroendocrinology, 37: 1949-53 (2012).
A1.64. Celik, O., E. Yilmaz, N. Celik, Y. Minareci, I. Turkcuoglu, Y. Simsek, A. Karaer, E. Celik, and S. Aydin, “Salusins, newly identified regulators of hemodynamics and mitogenesis, increase in policystic ovarian syndrome,” Gynecol Endocrinol., 29: 83-6 (2012).
A1.65. Aydin, S., M.N. Eren, S. Aydin, İ.H. Ozercan, and A.F. Dagli, “The bioactive peptides salusins and apelin–36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass,” Peptides, 37: 233-9 (2012).
A1.66. Nurkalem, C., H. Celik, F. Dagli, B. Gurates, B. Kavak, Z. Dogan, Y. Baykus, and S. Aydin, “Ghrelin and obestatin expression in serous ovarian tumours,” Gynecol Endocrinol, 28: 941-4 (2012).
A2. INTERNATIONAL TECHNIC NOTES AND LETTERS
A2.1. Aydin, S., “Proposal for the abbreviation of ghrelin - the appetite hormone,” Horm Res, 66, 206 (2006).
A2.2. Aydin, S., “Increased ghrelin levels in epileptic patients,” Seizure, 15, 658 (2006).
A2.3. Aydin, S., “Discrepancy of milk ghrelin level,” Acta Pædiatr, 96, 320 (2007).
A2.4. Aydin, S., H. Geckil, A. Karaoglu, and E.T. Elkiran, “Ghrelin: A novel peptide with therapeutic effect in certain cancers?,” Med Hypotheses, 69, 1157-8 (2007).
A2.5. Aydin, S., “Are ghrelin levels really elevated in epileptic patients?,” Seizure, 16, 469 (2007).
A2.6. Aydin, S., A.O. Barim, and O. Akin, “Ghrelin and leptin concentrations in obsessive-compulsive disorder: Commentary,” Prog Neuropsychopharmacol Biol Psychiatry, 32, 601 (2008).
A2.7. Aydin, S., F. Erman, N. Kilic, and F. Sahpaz, “Des-acylated ghrelin, rather than acylated ghrelin, might be more valuable in ınflammatory bowel diseases,” Dig Dis Sci, 53, 2583 (2008).
A2.8. Aydin, S. and E. Dag, “Does ghrelin really ıncrease in epileptic children treated with valproate?,” J Child Neurol, 23, 1084 (2008).
A2.9. Kilic, N., S. Aydin, and A.O. Barim, “Hormonal alterations in prepubertal children with ıron deficiency,” Endocr J, 56, 309 (2009).
A2.10. Aydin, S., H. Geckil, N. Kilic, F. Erman, S.S. Kilic, and O. Yesilada, “Is ghrelin a natural anti-microbial agent?,” Turk J Med Sci, 38, 187 (2009).
A2.11. Aydin, S., “Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stoper,” J Int Med Res, 37, 279 (2009).
A2.12. Aydin, S., İ. Sahin, U. Demirel, and A. Aksoy, “To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?,” Metab Clin Exp, 60, e1 (2011).
A2.13. Aydin, S., “Lactulose in fat-free milk, rather than increased ghrelin and motilin level, might help for solving constipation: Author update,” Nutrition, 27, 731-2 (2011).
A2.14. Aydin, S., “Is it appropriate to study blood ghrelin and obestatin in Non-alcoholic Fatty Liver Disease (NAFLD) without using protease inhibitors?,” Ann Hepatol, 11, 145-6 (2012).
Copyright © 2020 Isaac Scientific Publishing Co. All rights reserved.